ARA 290
Description
A synthetic peptide derived from erythropoietin (EPO) designed to selectively target the innate repair receptor (IRR) to promote tissue protection and anti-inflammatory signaling without stimulating erythropoiesis.
Available in 10mg–50mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
ARA 290 from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
ARA 290 (Cibinetide) is supplied as a research-grade peptide for in vitro study. Synthetic research peptides of this class are widely used in laboratory studies of receptor signaling, tissue biology, and peptide pharmacology.
Every lot of ARA 290 is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| A synthetic peptide derived from erythropoietin (EPO) designed to selectively target the innate repair receptor (IRR) to promote tissue protection and anti-inflammatory signaling without stimulating erythropoiesis. | |
|---|---|
| Key Benefits & Highlights | |
| Targeted IRR Activation | Interacts specifically with the innate repair receptor to initiate cellular protection pathways and attenuate tissue damage response. |
| Non-Erythropoietic Design | Engineered to decouple tissue protective properties from red blood cell production, avoiding unwanted hematological changes during testing. |
| Neuroprotective & Peripheral Nerve Focus | Widely investigated in cellular and small-animal models for mitigating neuropathic distress and supporting nerve fiber integrity. |
| High Chemical Purity | Synthesized and verified to meet strict purity thresholds, minimizing confounding variables in biological testing. |
| Standardized Research Reagent | Formulated for precise, repeatable results across in vitro assays, cellular injury models, and inflammatory pathway research. |
| Feature Summary | |
| Product Class | Non-Erythropoietic Peptide / Innate Repair Receptor Agonist |
| Primary Application | In vitro neuroprotection & anti-inflammatory pathway research |
| Grade | Laboratory / Research Grade Only |